Suraksha Clinic and Diagnostic
Lot Size
1 Lot = 34 Qty |
Min Investment
₹14994 |
Subscription
Undersubscribed |
Listing Gain
0(Points) |
IPO Details
Open Date
Nov 29, 2024 |
Close Date
Dec 03, 2024 |
Allotment Date
Dec 04, 2024 |
Allotment Date
Dec 04, 2024 |
Refund Initiation
Dec 05, 2024 |
Demat Transfer
Dec 05, 2024 |
Listing Date
Dec 06, 2024 |
Fresh Issue
0 |
Offer For Sale
846.25 |
Issue Price
₹420 to ₹441 |
Face Value
₹2 |
Issue Type
Fresh Issue |
Total Issue Size
846.25 CR |
QIB + NII Quota
50 + 15% |
Retail Quota
35% |
Listing On
NSE & BSE |
Registrar
KFin Technologies Private Ltd |
Company Financial Rusult In Crore
PERIOD | ASSET | REVENUE | PROFIT |
---|---|---|---|
30-Jun-2024 | 314.20 | 61.85 | 7.67 |
31-Mar-2024 | 300.21 | 222.26 | 23.13 |
31-Mar-2023 | 281.20 | 193.69 | 6.07 |
31-Mar-2022 | 275.96 | 225.77 | 20.82 |
About The Company
On March 15, 2005, Suraksha Diagnostic Limited began its operation as a leading technology-driven diagnostic chain in India. The company provides integrated pathology, radiology, and medical consultancy services under one umbrella with an excellent operational network. As of date, more than 2,300 specialized tests in various disciplines of medicine meet diverse health needs.
Comprehensive Diagnostic Network: Suraksha Diagnostic runs a state-of-the-art central reference laboratory supported by 8 satellite laboratories and 194 customer contact points, including 48 diagnostic centers and 146 sample collection centers. This extensive infrastructure thus provides seamless patient experience, convenient and accessible across eastern and northeastern India.
Besides offering diagnostic services, over 120 polyclinics function in 43 diagnostic centers with more than 750 doctors across the organization to offer in-house medical consultations for improving patient care.
Suraksha Diagnostic - Strength and Weakness
Strength
- Leading presence in the eastern Indias diagnostic market with growth potential in a fragmented industry.
- Provides comprehensive diagnostics, including pathology, radiology, and consultations.
- Recognized brand with a focus on quality, supporting individual consumer business.
- Equipped with advanced clinical infrastructure and skilled personnel for reliable services.
Weakness
- The companys business relies heavily on West Bengal, and any loss of business in this region may negatively impact overall performance.
- The company depends on third-party vendors for testing equipment, and supply disruptions could affect operations.
- The diagnostics industry is highly competitive, which could lead to price cuts that affect profits.